| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
3,000 |
2,231 |
$261K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
965 |
722 |
$175K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,212 |
2,303 |
$151K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
911 |
693 |
$89K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
438 |
361 |
$81K |
| 36415 |
Collection of venous blood by venipuncture |
3,251 |
2,191 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
974 |
787 |
$80K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,308 |
955 |
$75K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
260 |
221 |
$73K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
321 |
221 |
$68K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,027 |
830 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,766 |
1,409 |
$67K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
586 |
144 |
$58K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
920 |
822 |
$52K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,071 |
913 |
$49K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
415 |
367 |
$47K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
688 |
470 |
$46K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
889 |
796 |
$41K |
| 84484 |
|
423 |
228 |
$38K |
| 80061 |
Lipid panel |
537 |
483 |
$30K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
171 |
163 |
$23K |
| 82550 |
|
402 |
265 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
191 |
146 |
$20K |
| 83735 |
|
464 |
350 |
$20K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
638 |
451 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
239 |
186 |
$19K |
| 83721 |
|
440 |
380 |
$18K |
| 81003 |
|
813 |
620 |
$17K |
| 80305 |
|
307 |
239 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
637 |
554 |
$15K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
342 |
319 |
$13K |
| 82553 |
|
97 |
50 |
$10K |
| T1015 |
Clinic visit/encounter, all-inclusive |
86 |
74 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
68 |
57 |
$6K |
| 81025 |
|
122 |
94 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
209 |
200 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
85 |
69 |
$4K |
| A0425 |
Ground mileage, per statute mile |
35 |
27 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
137 |
55 |
$4K |
| 82607 |
|
76 |
72 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
125 |
77 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
72 |
40 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19 |
18 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
38 |
28 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
38 |
26 |
$1K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
22 |
13 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
35 |
13 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
12 |
$956.28 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
22 |
19 |
$916.65 |
| 83605 |
|
21 |
14 |
$823.08 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
22 |
12 |
$780.96 |
| 71045 |
Radiologic examination, chest; single view |
14 |
13 |
$767.63 |
| 97010 |
|
41 |
12 |
$532.80 |
| 82746 |
|
71 |
66 |
$433.39 |